Compare Arkham (ARKM) vs Enzyme (MLN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Arkham vs Enzyme — how do they compare? Arkham trades at Rp1,998 (market cap Rp450,32M, Rp516,07M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Arkham is far larger — about 3.4× Enzyme's market cap, and Arkham's supply is capped (225,1M / 1B ARKM (23%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Arkham for 49 Days and Enzyme for 28 Days on average.
| ARKM | MLN | |
|---|---|---|
Market Cap | Rp450,32M | Rp134,13M |
Volume (24h) | Rp516,07M | Rp104,56M |
Circulating Supply | 225,1M / 1B ARKM (23%) | 3,3M MLN |
Typical Hold Time | 49 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKM is currently trading at Rp1,971 with a bearish technical signal, showing selling pressure across moving averages while oscillators remain neutral. The token trades below the pivot point of Rp2,048 with immediate support at Rp1,951. With only 23% of the maximum 1 million token supply in circulation and an average hold time of 49 days, the asset shows limited distribution but stable holding patterns among current investors.
The overall outlook remains cautious due to strong bearish technical signals and limited fundamental developments. Key opportunities include potential price stabilization near support levels, while major risks involve low liquidity with Rp453.71M market cap and the absence of recent ecosystem updates that could drive adoption.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134.13 million and circulating supply of 3.3 million tokens. The asset demonstrates relatively low volatility with a 28-day average hold time, suggesting stable holding patterns among current investors. Trading volumes appear subdued, indicating limited market participation and liquidity depth at current levels.
Overall outlook remains cautious due to thin liquidity and limited ecosystem developments. Key opportunities include potential protocol upgrades and ecosystem expansion, while major risks center around low trading volumes and regulatory uncertainty in the cryptocurrency space. Investors should monitor network activity and exchange listings for catalysts.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Arkham
Arkham is a blockchain analysis platform that uses artificial intelligence to deanonymize the blockchain and on-chain data. Arkham’s platform can be used for various purposes, such as tracking stolen funds, identifying fraudsters, verifying counterparties, auditing transactions, investigating hacks, and more. Arkham claims its platform can help combat the proliferation of crypto crimes and scams by incentivizing on-chain research.
Read more on ARKM →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
